Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Molecular Immunology
|
July 1, 1982
Somatic cell hybridization between bovine leukemia virus-infected lymphocytes and murine plasma cell tumors: cell fusion studies with bovine cells
I Davidson, S Katzav, H Ungar-Waron, et al.
Nature
|
May 23, 1985
Abrogation of metastatic properties of tumour cells by de novo expression of H-2K antigens following H-2 gene transfection
R Wallich, N Bulbuc, G J Hämmerling, et al.
Oncogene
|
September 21, 1995
Vav and Ras induce fibroblast transformation by overlapping signaling pathways which require c-Myc function
S Katzav, G Packham, M Sutherland, et al.
Experimental Hematology
|
April 1, 1996
Insulin-like growth factor-1 induces rapid tyrosine phosphorylation of the vav proto-oncogene product
S Uddin, A Yetter, S Katzav, et al.
Human Genetics
|
November 1, 1990
The human VAV proto-oncogene maps to chromosome region 19p12----19p13.2
C Martinerie, L A Cannizzaro, C M Croce, et al.
Invasion & Metastasis
|
January 1, 1985
Selecting, accelerating and suppressing interactions between macrophages and tumor cells
P De Baetselier, A Kapon, S Katzav, et al.
Oncogene
|
September 1, 1989
The trk oncogene abrogates growth factor requirements and transforms hematopoietic cells
S Katzav, D Martin-Zanca, M Barbacid, et al.
Journal of the National Cancer Institute
|
November 1, 1981
Metastatic properties conferred on nonmetastatic tumors by hybridization of spleen B-lymphocytes with plasmacytoma cells
P De Baetselier, E Gorelik, Z Eshhar, et al.
Journal of Immunogenetics
|
April 1, 1986
Manipulation of metastasis and tumour growth by transfection with histocompatibility class I genes
G J Hämmerling, D Klar, S Katzav, et al.
Nature
|
March 5, 1992
Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs
B Margolis, P Hu, S Katzav, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Molecular Immunology
|
July 1, 1982
Somatic cell hybridization between bovine leukemia virus-infected lymphocytes and murine plasma cell tumors: cell fusion studies with bovine cells
I Davidson, S Katzav, H Ungar-Waron, et al.
Nature
|
May 23, 1985
Abrogation of metastatic properties of tumour cells by de novo expression of H-2K antigens following H-2 gene transfection
R Wallich, N Bulbuc, G J Hämmerling, et al.
Oncogene
|
September 21, 1995
Vav and Ras induce fibroblast transformation by overlapping signaling pathways which require c-Myc function
S Katzav, G Packham, M Sutherland, et al.
Experimental Hematology
|
April 1, 1996
Insulin-like growth factor-1 induces rapid tyrosine phosphorylation of the vav proto-oncogene product
S Uddin, A Yetter, S Katzav, et al.
Human Genetics
|
November 1, 1990
The human VAV proto-oncogene maps to chromosome region 19p12----19p13.2
C Martinerie, L A Cannizzaro, C M Croce, et al.
Invasion & Metastasis
|
January 1, 1985
Selecting, accelerating and suppressing interactions between macrophages and tumor cells
P De Baetselier, A Kapon, S Katzav, et al.
Oncogene
|
September 1, 1989
The trk oncogene abrogates growth factor requirements and transforms hematopoietic cells
S Katzav, D Martin-Zanca, M Barbacid, et al.
Journal of the National Cancer Institute
|
November 1, 1981
Metastatic properties conferred on nonmetastatic tumors by hybridization of spleen B-lymphocytes with plasmacytoma cells
P De Baetselier, E Gorelik, Z Eshhar, et al.
Journal of Immunogenetics
|
April 1, 1986
Manipulation of metastasis and tumour growth by transfection with histocompatibility class I genes
G J Hämmerling, D Klar, S Katzav, et al.
Nature
|
March 5, 1992
Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs
B Margolis, P Hu, S Katzav, et al.
Page
of 4